Abiopharma

New Form SCHEDULE 13D/A - I-Mab Filed: 2025-08-07 AccNo: 0001415889-25-021279 Size: 26 KB

New Form 10-Q - Coherus Oncology, Inc. Filed: 2025-08-07 AccNo: 0001558370-25-010803 Size: 11 MB

New Form 8-K - Coherus Oncology, Inc. Filed: 2025-08-07 AccNo: 0001558370-25-010802 Size: 548 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form S-8 - Axsome Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-105192 Size: 342 KB

New Form S-8 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Filed: 2025-08-07 AccNo: 0001299130-25-000158 Size: 517 KB

New Form 4 - BECTON DICKINSON & CO Filed: 2025-08-07 AccNo: 0000010795-25-000075 Size: 5 KB

New Form SCHEDULE 13D - Mallinckrodt plc Filed: 2025-08-07 AccNo: 0001641172-25-022600 Size: 27 KB

New Form 4 - BridgeBio Pharma, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-105185 Size: 19 KB

New Form 10-Q - Elicio Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001601485-25-000111 Size: 7 MB

New Form 4 - Bausch & Lomb Corp Filed: 2025-08-07 AccNo: 0001127602-25-020243 Size: 4 KB

New Form S-8 - LIFECORE BIOMEDICAL, INC. \DE\ Filed: 2025-08-07 AccNo: 0001005286-25-000110 Size: 254 KB

UTHR: Notification

New Form 8-K - NutriBand Inc. Filed: 2025-08-07 AccNo: 0001213900-25-073116 Size: 841 KB Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 8-K - DocGo Inc. Filed: 2025-08-07 AccNo: 0001822359-25-000077 Size: 583 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Bausch & Lomb Corp Filed: 2025-08-07 AccNo: 0001127602-25-020242 Size: 4 KB